Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-01-505569
Filing Date
2001-03-30
Accepted
2001-03-30 00:00:00
Documents
3
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405 a2043166z10-k405.htm 10-K405 541425
2 EX-23.1 a2043166zex-23_1.htm EX-23.1 2145
3 G308835.JPG g308835.jpg GRAPHIC 75145
  Complete submission text file 0000912057-01-505569.txt   620387
Mailing Address 240 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 240 E GRAND AVE SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-29889 | Film No.: 1585252
SIC: 8731 Services-Commercial Physical & Biological Research